MTI 100: Global Medtech Recovers Core Growth After A Year Like No Other

Commentary on dynamics and influential factors for companies in MTI's Top 100 Medtech Listings for 2022-23

With many medtechs restructuring for core growth in the post-pandemic era, Abbott relied on organic growth in 2022 to move to the top of the global medtech ranking. The strength of the US dollar was not kind to companies reporting in local currencies on converting revenues to dollars.

digital world
• Source: Shutterstock

It has been several years since Medtronic has not topped the annual Medtech 100 ranking of global medical device, diagnostic and digital health companies by revenues. But that was the outcome after the latest fiscal year-end reports were filed.

Both Medtronic and Abbott exceeded $31.2bn in revenues, with Abbott shading the contest by $40m after Medtronic reported a 1.4% decrease in 2022-23 (FY2023) revenues

More from Company Rankings

More from Market Intelligence